PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublications in collaboration with researchers from Washington University in St. Louis School of Medicine (2)
2022
2021
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 5, pp. 643-654